Signed in as:
filler@godaddy.com
Our Team
Priti Shah OTR, CHT
Priti is a highly innovative OT, who has invented a Topical Anti-Spasmodic drug to prevent debilitating spasms, without limiting client’s ability to function and perform normal day to day activities.
Known to be passionate about recovering functions in clients with complicated issues, by thinking outside the box and using various modalities after consideration of proper body mechanics.
From 1988 to 2010, Priti has worked for various therapy companies in Georgia, Texas and New Jersey.
In 2010, she founded Allies in Hand Therapy and has successfully ran that company till now, which is currently in expansion mode.
She is a dynamic Occupational Therapist, having worked in all aspects of Occupational Therapy and beyond, such lymphedema, dry needling, Kinesio taping.
Experienced in treating complicated diagnoses affecting function and independence of individuals. Is recognized by local medical community, as a go to therapist for complicated cases in Northern NJ.
Over the years, she has developed various splints and orthotics to improve the alignment and biomechanics of hand function.
Mandar Shah PhD
Dr. Mandar Shah is an innovative pharmaceutical professional, having expertise in developing generic, Rx, OTC and surgical products in large and small-sized pharmaceutical companies in USA and India.
Inventor of more than 50 patents and launched a few innovative products.
Experienced in solving scientific, strategic, and manufacturing issues, along with the understanding of business development and client interface.
Over the years, developed high level of skill for assessing, developing and coaching talent; excellent interpersonal skills; and ability to communicate with all levels of organization. Successful at integrating multi-site projects and aligning culturally diverse teams around strategic vision and profit model.
Recognized for developing innovative Business/Regulatory/Legal strategies to fuse product conceptualization, development and product positioning for optimizing market reach of many different dosage forms to achieve impressive turnaround.
Carry out benchmarking of the products in portfolio with other generic products and potential innovative products. Also benchmark other dosage forms for expansion into different verticals.
Specialize in ‘Evergreening’ of known drugs (creative new patent applications), developing non-infringing products, developing difficult-to-formulate and difficult-to-manufacture generic products.
Thomas Argentieri PhD
Dr. Thomas Argentieri is a Pharma and Biotech Executive with over 30 years of experience in academic and industrial R&D.
He earned his Ph.D. in pharmacology from Rutgers University focusing on ion channel biophysics, and received post-doctoral training at the University of Pennsylvania, after which he spent several years as an assistant professor in the UPenn's department of medicine studying mechanisms of cardiac arrhythmias.
After leaving academia, he become the Section Head at Berlex Pharmaceuticals, helping to build and lead their antiarrhythmic and antihypertensive drug discovery efforts putting 2 drugs into the clinic.
He later joined Wyeth Pharmaceuticals to direct their Urologic Disorders division where he oversaw development of treatments for overactive bladder.
During this time period he authored over 70 peer reviewed manuscripts, review articles and book chapters, and was awarded 10 patents. In 2004 I transitioned into business development, performing in - and out-licensing activities for the Pharm and Biotech conducting numerous deals on both the buy and sell side.
He is the founder of BioSense Solutions, providing scientific evaluation, market research, licensing and business development expertise to the pharmaceutical and biotech industries, and he currently serves on the editorial board of the Journal of Pharmacology and Experimental Therapeutics.